iVEAcare is a medical technology company dedicated to advancing the science and clinical application of vagus nerve stimulation (VNS) for individuals living with epilepsy. We are focused on developing innovative neuromodulation technologies with the potential to improve the lives of patients and families affected by neurological disorders.
Every decision begins with a commitment to the patients and families we serve. We center every effort on safety, dignity, and delivering meaningful outcomes.
Meaningful innovation is grounded in strong science. Our approach is driven by thoughtful clinical research, physician collaboration, and continuous learning.
We are dedicated to expanding knowledge and exploring new possibilities in neuromodulation to help shape the future of epilepsy treatment.
Updates on our clinical studies will be shared here and on ClinicalTrials.gov as they become available.
